| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K03911514 |
| PharmacoGx | BRD-K03911514 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C1orf109 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | MMP28 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | ZNF268 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | PLOD2 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.001 |
| mRNA | LIN7C | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | HMGN4 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | CNTN4 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | SETD1B | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | MUC15 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | MAFA | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
